Statins and diabetes mellitus: risks and benefits
Patients with diabetes mellitus (DM) are at a high risk of cardiovascular events (CVE). Currently, the predominant clinical strategy of the CVE prevention in DM patients is aggressive lowering of low-density lipoprotein cholesterol and blood pressure levels. In this clinical group, statins are among...
Saved in:
Main Authors: | O. M. Drapkina, O. N. Korneeva, A. F. Sheptulina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2012-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2038 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015-09-01) -
STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01) -
Statin utilization and its predictors for the primary prevention of cardiovascular disease among type 2 diabetic patients in a resource-limited setting
by: Feyisa Assefa Dhaba, et al.
Published: (2025-07-01) -
Statins associated diabetes: state of the problem in 2018
by: Zh. D. Kobalava, et al.
Published: (2018-09-01) -
The effects of statins on cytokines an endotelin-1 in patients with chronic obstructive pulmonary disease and diabetes mellitus
by: S. A. Nedomolkina, et al.
Published: (2021-06-01)